Thu, Aug 21, 2014, 11:00 AM EDT - U.S. Markets close in 5 hrs.

Recent

% | $
Quotes you view appear here for quick access.

Amarantus Bioscience Holdings, Inc Message Board

  • solantey@sbcglobal.net solantey Apr 4, 2013 8:15 AM Flag

    Something To Consider

    Strong accumulation continues. The float is drying up. Anyone who wants in for the long term upside had better buy soon or they'll be paying several times the current price in a few weeks.

    Each of the new board members have over 500 connections on Linkedin. Please note who were some of the recent viewers of their profiles.

    Each is a potential new shareholder. The word is getting out to the market.

    There are some very prominent individuals viewing their profiles. Take the time to view these individual's profiles. I would bet they're within six degrees of every C.E.O. of every major drug company in the world.

    Dr. Adam J. Simon

    Recent viewers:

    • Jim Ray
    Senior Director at Envoy Therapeutics,...
    • Joseph Vacca
    Head of Early Success Sharing...
    • David Devilbiss
    Founder of NexStepBiomarkers, LLC.
    • Paul Shughrue
    Research at Prothena Biosciences
    • Mary J. Savage
    Scientific Director at Merck and Company
    • Sethu Sankaranarayanan
    Scientist at Bristol-Myers Squibb
    • Jeffrey Vivian
    • Peter Como
    Neuropsychologist at Food and Drug...
    • Annie Liang
    Research Biologist at Merck

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AMBS
0.109-0.003(-2.77%)10:44 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.